Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioma × Imiquimod × Clear all

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13 Temozolomide 9 Specimen Handling 8 X-Rays 6 Radiotherapy 6 Biopsy 6 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 trametinib 4 olaparib 3 dabrafenib 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 pembrolizumab 2 niraparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 atezolizumab 2 Surveys and Questionnaires 2 Radiation 2 Proton Therapy 2 Lomustine 2 Irinotecan 2 Gemcitabine 2 CLR1404 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808245 2025-09-22

INTERCEPT-H3

German Cancer Research Center

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡